In Vitro Activity of Omadacycline against 7,200 Bacterial Clinical Isolates Representing Multiple Infection Types from the United States (2024–2025)

In Vitro Activity of Omadacycline against 7,200 Bacterial Clinical Isolates Representing Multiple Infection Types from the United States (2024–2025). Lead author: Michael D. Huband, presented at IDWeek 2026, Oct 24, Washington D.C., USA
Poster P-383